Find Out What’s New in MS Research from MSAA

The Multiple Sclerosis Association of America (MSAA) is proud to share a new series of online research-update articles, “What’s New in MS Research,” to keep you informed on the latest happenings in the world of MS research. Published every other month, these articles will feature current MS-research topics, ranging from highlights of major international MS conferences and updates on trials with experimental disease-modifying therapies, to new findings on the development of the disease, symptom management, and quality of life issues.

When it comes to remembering, togetherness helps

A study highlighted in this first edition includes the effectiveness of group, cognitive rehabilitation (CR) therapy in women with relapsing-remitting MS (RRMS). Cognitive impairment eventually affects up to two-thirds of people with MS, which reinforces the importance of continued studies around this common MS symptom.

More sun early in life may mean lower MS risk later in life

Lifetime sun exposure and associations with MS is another prevalent topic included in “What’s New in MS Research.” This study extends a line of inquiry into the association between Vitamin D levels and MS risk. Sunlight is a major source of Vitamin D, and research has shown that many people with MS have relatively low levels of the vitamin. Additionally, epidemiological research has shown MS to be more prevalent in northern countries, where individuals receive less year-round sun exposure in lower latitudes.

Other MS-related topics in this edition include:

To read all of the studies summarized in “What’s New in MS Research” please visit this link on MSAA’s website.

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Comments

Poll